Rex Nilson, DPM
Foot & Ankle Surgery · Edmonds, WANPI 1386744324
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $17,690 of the $22,623 with a category attached, or 78.2%. Amgen accounts for 95.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $16,574 and has fallen 98.2% since, to $300 in 2025. Among foot & ankle surgery clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $266.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$22K
- Bioventus LLC$311
- Smith+Nephew$96
- Zimmer Biomet$91
- Stryker$72
- Orthofix Medical, Inc.$50
- plus $301 from 12 others
What the payments were for
- Speaking & faculty fees$17,69078%
- Travel & lodging$3,18914%
- Food & beverage$1,7448%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 50 | $21,701 |
| Bioventus LLC | 9 | $311 |
| Smith+Nephew | 4 | $96 |
| Zimmer Biomet | 4 | $91 |
| Stryker | 2 | $72 |
| Orthofix Medical, Inc. | 2 | $50 |
| Summit Surgical Corp. | 1 | $49 |
| Heron Therapeutics, Inc. | 2 | $39 |
| Anika Therapeutics, Inc. | 1 | $32 |
| Paragon 28, Inc. | 2 | $27 |
| Solventum Corporation | 1 | $24 |
| Fusion Orthopedics USA, LLC | 1 | $23 |
| Alfasigma USA, Inc. | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $20 |
| Avanos Medical | 1 | $20 |
| Zyla Life Sciences, Inc. | 1 | $18 |
| AbbVie | 1 | $17 |
| Kerecis Limited | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$20,775
How this compares
$22,623 in reported general payments places this provider in the 90th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 27 | $1,005 |
| Celecoxib | 32 | $942 |
| Mupirocin | 70 | $631 |
| Colchicine | 15 | $532 |
| Cephalexin | 50 | $452 |
| Gabapentin | 40 | $434 |
| Terbinafine Hcl | 31 | $350 |
| Allopurinol | 42 | $310 |
| Pregabalin | 11 | $177 |
| Meloxicam | 21 | $137 |
| Methylprednisolone | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Edmonds
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
- Garrett PereskoMorton$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.